Vaccination against syncytial virus for premature babies has officially started. Photo: illustrative.
In this last week of March, the immunization of premature babies against respiratory syncytial virus (RSV) began. The General Hospital of Barrio Obrero was the first to be enabled and other reference centers will be added later.
The hospital located in the Obrero neighborhood of Asunción was chosen for start the vaccination scheme against respiratory syncytial virusconsidered as the
most common seasonal microbe which causes infections in the lungs and airways.
this virus generally circulates between the autumn and winter seasoncoinciding with the drop in temperature and the increase in respiratory symptoms, and It is the cause of serious infections such as bronchiolitis in children under 2 years of age.
It may interest you: Avian flu in humans “is difficult to detect”, they warn: “It looks like any other flu”
In our country, the monoclonal supplement called palivizumab is applied to babies born prematurely weighing less than 1,500 grams, who have certain diseases of the heart or lungs, among other inclusion criteria. This antibody prevents the premature infant from re-entering the intensive care unit after medical discharge and reduces hospitalizations for this infection by 50%.
The RSV immunization campaign runs until mid-Augustwhen to complete the monthly application of a total of 5 doses recommended.
The other health centers that are part of the program are the Acosta Ñu Pediatric Hospital, the Itauguá National Hospital, the San Pablo Maternal and Child Hospital, as well as the Social Welfare Institute (IPS).
Also read: Petropar announces diesel reduction for Easter
The Association of Parents of Premature Babies recently stated your concern to the Ministry of Public Health before the possibility that they do not have the necessary doses to complete the scheme with the 5 optimal recommended doses.
It should be remembered that Dr. Derlis León, director of Strategic Supplies of the Ministry of Healthhad guaranteed that the health portfolio It has a good stock of the antibody.but that will also speed up the processes for the acquisition of more doses.
